Scarica l'app Stockscreener
170.38
5.23%
-9.41
Dopo l'orario di chiusura:
170.38
Precedente Chiudi:
$179.79
Aprire:
$176.5
Volume 24 ore:
1.01M
Relative Volume:
1.23
Capitalizzazione di mercato:
$10.05B
Reddito:
$551.35M
Utile/perdita netta:
$-189.33M
Rapporto P/E:
-51.76
EPS:
-3.2916
Flusso di cassa netto:
$-35.09M
1 W Prestazione:
-5.53%
1M Prestazione:
-6.09%
6M Prestazione:
+65.18%
1 anno Prestazione:
+94.68%
Intervallo 1D:
$169.26
$179.96
Intervallo di 1 settimana:
$169.26
$185.35
Portata 52W:
$73.16
$191.62
Glaukos Corp Stock (GKOS) Company Profile
Nome
Glaukos Corp
Settore
Industria
Telefono
949-367-9600
Indirizzo
1 GLAUKOS WAY, ALISO VIEJO, CA
Compare GKOS vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corp
|
170.38 | 10.60B | 551.35M | -189.33M | -35.09M | -3.2916 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Glaukos Corp Stock (GKOS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-07-06 | Iniziato | H.C. Wainwright | Buy |
| 2025-10-27 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-10-01 | Iniziato | Goldman | Buy |
| 2025-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2024-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-12-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2024-05-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-12-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-11-28 | Iniziato | Truist | Buy |
| 2023-11-08 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-19 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-04 | Iniziato | Needham | Buy |
| 2022-07-12 | Aggiornamento | Stifel | Hold → Buy |
| 2022-02-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-11-03 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-07-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Aggiornamento | Citigroup | Sell → Neutral |
| 2020-12-09 | Iniziato | Oppenheimer | Perform |
| 2020-11-17 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-06-15 | Iniziato | Jefferies | Hold |
| 2020-03-05 | Iniziato | Citigroup | Sell |
| 2020-02-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-01-06 | Aggiornamento | Berenberg | Hold → Buy |
| 2019-12-12 | Downgrade | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | Iniziato | BTIG Research | Neutral |
| 2018-08-30 | Iniziato | Berenberg | Hold |
| 2018-08-29 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-08-03 | Reiterato | Stifel | Hold |
| 2018-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-04-13 | Downgrade | Stifel | Buy → Hold |
| 2018-03-01 | Reiterato | Cantor Fitzgerald | Buy |
| 2017-03-02 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-01-06 | Aggiornamento | Stifel | Hold → Buy |
| 2016-10-27 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Glaukos Corp Borsa (GKOS) Ultime notizie
Glaukos Corp (GKOS) Shares Fall 5.2% -- What GF Score of 77 Tells Investors - GuruFocus
Why Glaukos Shares Are Trading Lower Today - Quiver Quantitative
If You Invested $1000 In Glaukos Stock 10 Years Ago, You Would Have This Much Today - Benzinga
Glaukos at Wells Fargo conference: launch ramps, reimbursement risks - Investing.com
Glaukos at Wells Fargo conference: launch ramps, reimbursement risks By Investing.com - Investing.com Canada
Is Glaukos Corp (GKOS) Overvalued After 4.3% Rally? GF Value Say - GuruFocus
Glaukos Corp (NYSE: GKOS) Share Price, GKOS Stock News, GKOS Share Price & Updates - Kalkine
Enterprise value to EBITDA forward of Glaukos Corp – LSX:A14VCK - TradingView
Precipio Inc. (PRPO) Peer Comparison – Compare with Others - Value Research
Mesa Laboratories Inc. (MLAB) Peer Comparison – Compare with Others - Value Research
Bruker Corporation (BRKR) Peer Comparison – Compare with Others - Value Research
Repligen Corporation (RGEN) Peer Comparison – Compare with Others - Value Research
Quidel Corporation (QDEL) Peer Comparison – Compare with Others - Value Research
Heska Corporation (HSKA) Peer Comparison – Compare with Others - Value Research
UFP Technologies Inc. (UFPT) Peer Comparison – Compare with Others - Value Research
Natus Medical Incorporated (NTUS) Peer Comparison – Compare with Others - Value Research
Repro Med Systems Inc. (KRMD) Peer Comparison – Compare with Others - Value Research
Allied Healthcare Products Inc. (AHPI) Peer Comparison – Compare with Others - Value Research
Codex DNA Inc (DNAY) Peer Comparison – Compare with Others - Value Research
GlucoTrack Inc (GCTK) Peer Comparison – Compare with Others - Value Research
InspireMD Inc. (NSPR) Peer Comparison – Compare with Others - Value Research
IsoPlexis Corporation (ISO) Peer Comparison – Compare with Others - Value Research
Pulse Biosciences Inc (DE) (PLSE) Peer Comparison – Compare with Others - Value Research
Glaukos chief development officer sells $2.48m in shares By Investing.com - Investing.com Nigeria
Glaukos chief development officer sells $2.48m in shares - Investing.com
Haemonetics Corporation (HAE) Peer Comparison – Compare with Others - Value Research
Glaukos stock trades at $179 as investors weigh recent growth and valuation - ad-hoc-news.de
ICU Medical Inc. (ICUI) Peer Comparison – Compare with Others - Value Research
Trinity Biotech plcADR Peer Comparison – Compare with Others - Value Research
Acutus Medical Inc (AFIB) Peer Comparison – Compare with Others - Value Research
SS Innovations International Inc. (SSII) Peer Comparison – Compare with Others - Value Research
Bioventus Inc. Class A (BVS) Peer Comparison – Compare with Others - Value Research
Omnicell Inc. ($0.001 par value) (OMCL) Peer Comparison – Compare with Others - valueresearchonline.com
MaxCyte Inc. (MXCT) Peer Comparison – Compare with Others - valueresearchonline.com
Glaukos Corp (GKOS) Key Financial Ratios – Valuation, Profitability & More - Value Research
Glaukos (NYSE: GKOS) insider eyes multimillion-dollar stock sale - Stock Titan
Glaukos (GKOS) Up 8% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Aethlon Medical Inc. (AEMD) Peer Comparison – Compare with Others - Value Research
Vivos Therapeutics Inc. (VVOS) Peer Comparison – Compare with Others - Value Research
Dentsply Sirona Inc (XRAY) Peer Comparison – Compare with Others - Value Research
Myriad Genetics Inc. (MYGN) Peer Comparison – Compare with Others - Value Research
TransMedics Group Inc. (TMDX) Peer Comparison – Compare with Others - Value Research
Bionano Genomics Inc. (BNGO) Peer Comparison – Compare with Others - Value Research
Innovative Eyewear Inc (LUCYW) Peer Comparison – Compare with Others - Value Research
Glaukos Corp (GKOS) Peer Comparison – Compare with Others - Value Research
Here's How Much $100 Invested In Glaukos 5 Years Ago Would Be Worth Today - Benzinga
Why Is Glaukos (NYSE:GKOS) in Focus After Record Quarterly Sales? - Kalkine Media
Zacks Research Issues Positive Estimate for Glaukos Earnings - MarketBeat
Glaukos (GKOS) Stock Looks Pricey On High Growth Expectations - Sahm
BlackRock Inc. Takes Position in Glaukos Corporation $GKOS - MarketBeat
Glaukos Corp stock hits all-time high at 190.27 USD By Investing.com - Investing.com South Africa
Glaukos Corp Azioni (GKOS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.29%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):